16 сент. 2024 г. · Advice and warnings for the use of Zanamivir (Relenza) during pregnancy. FDA Pregnancy Category C - Risk cannot be ruled out.

20 окт. 2016 г. · Pregnant women can and should receive a category C drug when the possible benefits of using the drug are more likely than the possible risk of ...

Zanamivir. Article · Talk. Language; Watch · Edit. Zanamivir is a medication ... Pregnancy category. AU : B1. Routes of administration, Inhalation, intravenous.

15 сент. 2022 г. · Oral oseltamivir, zanamivir, and peramivir are "Pregnancy Category C" medications, indicating that controlled clinical studies have not been ...

Zanamivir is classified as a pregnancy category C agent. Orally inhaled zanamivir is generally well tolerated, and the frequencies of complaints are not ...

Pregnancy: Category C: Risk unknown. Human studies inadequate. Monitoring Requirements: None. Brand names/Manufacturer: Relenza® ...

Pregnancy Category C. There are no adequate and well-controlled studies of zanamivir in pregnant women. Zanamivir should be used during pregnancy only if the ...

Oseltamivir and zanamivir are "Pregnancy Category C" medications, indicating that no clinical studies have been conducted to assess the safety of these ...

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B1 US FDA pregnancy category: C

Pregnancy Categories. A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk. B: May be acceptable. Either animal ...